Free Trial
NYSE:CC

Chemours (CC) Stock Price, News & Analysis

Chemours logo
$13.81 -0.24 (-1.71%)
Closing price 07/11/2025 03:59 PM Eastern
Extended Trading
$13.80 -0.01 (-0.04%)
As of 07/11/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Chemours Stock (NYSE:CC)

Key Stats

Today's Range
$13.48
$13.91
50-Day Range
$9.41
$14.05
52-Week Range
$9.13
$25.54
Volume
3.89 million shs
Average Volume
2.54 million shs
Market Capitalization
$2.07 billion
P/E Ratio
69.05
Dividend Yield
2.53%
Price Target
$17.33
Consensus Rating
Moderate Buy

Company Overview

Chemours Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
89th Percentile Overall Score

CC MarketRank™: 

Chemours scored higher than 89% of companies evaluated by MarketBeat, and ranked 30th out of 186 stocks in the basic materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Chemours has received a consensus rating of Moderate Buy. The company's average rating score is 2.56, and is based on 5 buy ratings, 4 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Chemours has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Chemours' stock forecast and price target.
  • Earnings Growth

    Earnings for Chemours are expected to grow by 33.50% in the coming year, from $2.03 to $2.71 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Chemours is 69.05, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.84.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Chemours is 69.05, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 92.75.

  • Price to Book Value per Share Ratio

    Chemours has a P/B Ratio of 3.41. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Chemours' valuation and earnings.
  • Percentage of Shares Shorted

    12.33% of the float of Chemours has been sold short.
  • Short Interest Ratio / Days to Cover

    Chemours has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

    Short interest in Chemours has recently increased by 27.77%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Chemours pays a meaningful dividend of 2.53%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Chemours does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Chemours is 175.00%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Dividend Sustainability

    Based on earnings estimates, Chemours will have a dividend payout ratio of 12.92% next year. This indicates that Chemours will be able to sustain or increase its dividend.

  • Read more about Chemours' dividend.
  • Percentage of Shares Shorted

    12.33% of the float of Chemours has been sold short.
  • Short Interest Ratio / Days to Cover

    Chemours has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

    Short interest in Chemours has recently increased by 27.77%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Chemours has a news sentiment score of 0.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Basic Materials companies.
  • News Coverage This Week

    MarketBeat has tracked 19 news articles for Chemours this week, compared to 8 articles on an average week.
  • Search Interest

    10 people have searched for CC on MarketBeat in the last 30 days. This is an increase of 11% compared to the previous 30 days.
  • MarketBeat Follows

    7 people have added Chemours to their MarketBeat watchlist in the last 30 days. This is an increase of 17% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Chemours insiders have bought more of their company's stock than they have sold. Specifically, they have bought $251,573.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 0.47% of the stock of Chemours is held by insiders.

  • Percentage Held by Institutions

    76.26% of the stock of Chemours is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Chemours' insider trading history.
Receive CC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter.

CC Stock News Headlines

What is Zacks Research's Estimate for Chemours Q4 Earnings?
What is Zacks Research's Forecast for Chemours Q2 Earnings?
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
See More Headlines

CC Stock Analysis - Frequently Asked Questions

Chemours' stock was trading at $16.90 at the beginning of 2025. Since then, CC stock has decreased by 18.3% and is now trading at $13.81.

The Chemours Company (NYSE:CC) announced its quarterly earnings data on Tuesday, May, 6th. The specialty chemicals company reported $0.13 EPS for the quarter, missing analysts' consensus estimates of $0.19 by $0.06. The company's quarterly revenue was up .4% on a year-over-year basis.
Read the conference call transcript
.

Chemours' top institutional shareholders include Wealth Enhancement Advisory Services LLC (0.01%) and Parallel Advisors LLC. Insiders that own company stock include Mark Newman, Damian Gumpel, Shane Hostetter, Alisha Bellezza, Matthew S Abbott, Diane I Picho and Alvenia Scarborough.
View institutional ownership trends
.

Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Chemours investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), AT&T (T), Tesla (TSLA), Chevron (CVX) and JPMorgan Chase & Co. (JPM).

Company Calendar

Last Earnings
5/06/2025
Ex-Dividend for 6/16 Dividend
5/16/2025
Record date for 6/16 Dividend
5/19/2025
Dividend Payable
6/16/2025
Today
7/12/2025
Next Earnings (Estimated)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
CHEM - DIVERSIFD
Sub-Industry
Chemicals
Current Symbol
NYSE:CC
CIK
1627223
Fax
N/A
Employees
6,000
Year Founded
N/A

Price Target and Rating

High Price Target
$27.00
Low Price Target
$13.00
Potential Upside/Downside
+25.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.56
Research Coverage
9 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.20
Trailing P/E Ratio
69.05
Forward P/E Ratio
6.80
P/E Growth
N/A
Net Income
$86 million
Net Margins
0.54%
Pretax Margin
0.99%
Return on Equity
23.82%
Return on Assets
2.07%

Debt

Debt-to-Equity Ratio
7.01
Current Ratio
1.75
Quick Ratio
0.83

Sales & Book Value

Annual Sales
$5.78 billion
Price / Sales
0.36
Cash Flow
$3.68 per share
Price / Cash Flow
3.75
Book Value
$4.05 per share
Price / Book
3.41

Miscellaneous

Outstanding Shares
149,670,000
Free Float
148,971,000
Market Cap
$2.07 billion
Optionable
Optionable
Beta
1.65

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NYSE:CC) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners